Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/99956
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium |
Author: | Chong, C. Drury, N. Licari, G. Frenneaux, M. Horowitz, J. Pagano, D. Sallustio, B. |
Citation: | European Journal of Clinical Pharmacology, 2015; 71(12):1485-1491 |
Publisher: | Springer |
Issue Date: | 2015 |
ISSN: | 0031-6970 1432-1041 |
Statement of Responsibility: | Cher-Rin Chong, Nigel E. Drury, Giovanni Licari, Michael P. Frenneaux, John D. Horowitz, Domenico Pagano, Benedetta C. Sallustio |
Abstract: | Purpose: Perhexiline is a prophylactic anti-ischaemic agent with weak calcium antagonist effect which has been increasingly utilised in the management of refractory angina. The metabolic clearance of perhexiline is modulated by CYP2D6 metaboliser status and stereoselectivity. The current study sought to (1) determine whether the acute accumulation of perhexiline in the myocardium is stereoselective and (2) investigate the relationship between duration of short-term therapy and the potential stereoselective effects of perhexiline within myocardium. Method: Patients (n = 129) from the active arm of a randomised controlled trial of preoperative perhexiline in cardiac surgery were treated with oral perhexiline for a median of 9 days. Correlates of atrial and ventricular concentrations of enantiomers were sought via univariate followed by multivariate analyses. Results: Myocardial uptake of both (+) and (−) perhexiline was greater in ventricles than in atria, and there was more rapid clearance of (−) than (+) perhexiline. The main determinants of atrial uptake of both (+) and (−) perhexiline were the plasma concentrations [(+) perhexiline: β = −0.256, p = 0.015; (−) perhexiline: β = −0.347, p = 0.001] and patients’ age [(+) perhexiline: β = 0.300, p = 0.004; (−) perhexiline: β = 0.288, p = 0.005]. Atrial uptake of (+) enantiomer also varied directly with duration of therapy (β = 0.228, p = 0.025), while atrial uptake of (−) perhexiline varied inversely with simultaneous heart rate (β = −0.240, p = 0.015). |
Keywords: | Perhexiline metabolism pharmacokinetics drug uptake stereoselectivity |
Rights: | © Springer-Verlag Berlin Heidelberg 2015 |
DOI: | 10.1007/s00228-015-1934-8 |
Grant ID: | NHMRC |
Published version: | http://dx.doi.org/10.1007/s00228-015-1934-8 |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.